DIN 02527693 — ORLADEYO 150 MG
ORLADEYO is a capsule of Berotralstat marketed by BIOCRYST PHARMACEUTICALS INC. The full Berotralstat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02527693
- Brand name
- ORLADEYO
- Active ingredient
- Berotralstat
- Strength
- 150 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- BIOCRYST PHARMACEUTICALS INC
- Health Canada status
- MARKETED
- Drug class
- Plasma kallikrein inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.